Turner TJ, Zourray C, Schorge S, Lignani G. Recent advances in gene therapy for neurodevelopmental disorders with epilepsy. J Neurochem. 2021;157:229–62.

Article  CAS  PubMed  Google Scholar 

Simonato M, Bennett J, Boulis NM, Castro MG, Fink DJ, Goins WF, et al. Progress in gene therapy for neurological disorders. Nat Rev Neurol. 2013;9:277–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Joshi CR, Labhasetwar V, Ghorpade A. Destination brain: the past, present, and future of therapeutic gene delivery. J Neuroimmune Pharmacol. 2017;12:51–83.

Article  PubMed  PubMed Central  Google Scholar 

Keeler GD, Kumar S, Palaschak B, Silverberg EL, Markusic DM, Jones NT, et al. Gene therapy-induced antigen-specific Tregs inhibit neuro-inflammation and reverse disease in a mouse model of multiple sclerosis. Mol Ther. 2018;26:173–83.

Article  CAS  PubMed  Google Scholar 

Spronck EA, Brouwers CC, Vallès A, de Haan M, Petry H, van Deventer SJ, et al. AAV5-miHTT gene therapy demonstrates sustained huntingtin lowering and functional improvement in Huntington disease mouse models. Mol Ther-Methods Clin Dev. 2019;13:334–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flotte TR, Cataltepe O, Puri A, Batista AR, Moser R, McKenna-Yasek D, et al. AAV gene therapy for Tay-Sachs disease. Nat Med. 2022;28:251–9.

Article  CAS  PubMed  Google Scholar 

Ginn SL, Amaya AK, Alexander IE, Edelstein M, Abedi MR. Gene therapy clinical trials worldwide to 2017: an update. J Gene Med. 2018;20:e3015.

Article  PubMed  Google Scholar 

Mingozzi F, High KA. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet. 2011;12:341–55.

Article  CAS  PubMed  Google Scholar 

Snyder BR, Gray SJ, Quach ET, Huang JW, Leung CH, Samulski RJ, et al. Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery. Hum Gene Ther. 2011;22:1129–35.

Article  CAS  PubMed  Google Scholar 

Hayashi T, Akikawa R, Kawasaki K, Egawa J, Minamimoto T, Kobayashi K, et al. Macaques exhibit implicit gaze bias anticipating others’ false-belief-driven actions via medial prefrontal cortex. Cell Rep. 2020;30:4433–4444.e5.

Article  CAS  PubMed  Google Scholar 

Johnson TB, White KA, Brudvig JJ, Cain JT, Langin L, Pratt MA, et al. AAV9 gene therapy increases lifespan and treats pathological and behavioral abnormalities in a mouse model of CLN8-batten disease. Mol Ther. 2021;29:162–75.

Article  CAS  PubMed  Google Scholar 

Bartus RT, Baumann TL, Siffert J, Herzog CD, Alterman R, Boulis N, et al. Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients. Neurology. 2013;80:1698–701.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Szablowski JO, Lee-Gosselin A, Lue B, Malounda D, Shapiro MG. Acoustically targeted chemogenetics for the non-invasive control of neural circuits. Nat Biomed Eng. 2018;2:475–84.

Article  CAS  PubMed  Google Scholar 

Timbie KF, Mead BP, Price RJ. Drug and gene delivery across the blood-brain barrier with focused ultrasound. J Control Release. 2015;219:61–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thévenot E, Jordão JF, O’Reilly MA, Markham K, Weng Y-Q, Foust KD, et al. Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound. Hum Gene Ther. 2012;23:1144–55.

Article  PubMed  PubMed Central  Google Scholar 

Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Noninvasive MR imaging–guided focal opening of the blood-brain barrier in rabbits. Radiology. 2001;220:640–6.

Article  CAS  PubMed  Google Scholar 

Samiotaki G, Acosta C, Wang S, Konofagou EE. Enhanced delivery and bioactivity of the neurturin neurotrophic factor through focused ultrasound—mediated blood—brain barrier opening in vivo. J Cereb Blood Flow Metab. 2015;35:611–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Upright NA, Baxter MG. Effect of chemogenetic actuator drugs on prefrontal cortex-dependent working memory in nonhuman primates. Neuropsychopharmacology. 2020;45:1793–8.

Article  PubMed  PubMed Central  Google Scholar 

Rafii MS, Tuszynski MH, Thomas RG, Barba D, Brewer JB, Rissman RA, et al. Adeno-associated viral vector (serotype 2)–nerve growth factor for patients with alzheimer disease: a randomized clinical trial. JAMA Neurol. 2018;75:834–41.

Article  PubMed  PubMed Central  Google Scholar 

Hynynen K. Ultrasound for drug and gene delivery to the brain. Adv Drug Deliv Rev. 2008;60:1209–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Felix M-S, Borloz E, Metwally K, Dauba A, Larrat B, Matagne V, et al. Ultrasound-mediated blood-brain barrier opening improves whole brain gene delivery in mice. Pharmaceutics. 2021;13:1245.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Downs ME, Buch A, Sierra C, Karakatsani ME, Chen S, Konofagou EE, et al. Long-term safety of repeated blood-brain barrier opening via focused ultrasound with microbubbles in non-human primates performing a cognitive task. PloS One. 2015;10:e0125911.

Article  PubMed  PubMed Central  Google Scholar 

Staahl BT, Benekareddy M, Coulon-Bainier C, Banfal AA, Floor SN, Sabo JK, et al. Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes. Nat Biotechnol. 2017;35:431–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maggio I, Zittersteijn HA, Wang Q, Liu J, Janssen JM, Ojeda IT, et al. Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components. Gene Therapy. 2020;27:209–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339:819–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Swiech L, Heidenreich M, Banerjee A, Habib N, Li Y, Trombetta J, et al. In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat Biotechnol. 2015;33:102–6.

Article  CAS  PubMed  Google Scholar 

Chew WL, Tabebordbar M, Cheng JK, Mali P, Wu EY, Ng AH, et al. A multifunctional AAV–CRISPR–Cas9 and its host response. Nat Methods. 2016;13:868–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park H, Oh J, Shim G, Cho B, Chang Y, Kim S, et al. In vivo neuronal gene editing via CRISPR–Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer’s disease. Nat Neurosci. 2019;22:524–8.

Article  CAS  PubMed  Google Scholar 

Zhou H, Liu J, Zhou C, Gao N, Rao Z, Li H, et al. In vivo simultaneous transcriptional activation of multiple genes in the brain using CRISPR–dCas9-activator transgenic mice. Nat Neurosci. 2018;21:440–6.

Article  CAS  PubMed  Google Scholar 

Hana S, Peterson M, McLaughlin H, Marshall E, Fabian AJ, McKissick O, et al. Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in mice. Gene Ther. 2021;28:646–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Q, Zhou Y, Chen J, Huang N, Wang Z, Cheng Y. Gene therapy for drug-resistant glioblastoma via lipid-polymer hybrid nanoparticles combined with focused ultrasound. Int J Nanomed. 2021;16:185.

Article  Google Scholar 

Yan S, Tu Z, Li S, Li X-J. Use of CRISPR/Cas9 to model brain diseases. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;81:488–92.

Article  CAS  Google Scholar 

Wu W-H, Tsai Y-T, Justus S, Lee T-T, Zhang L, Lin C-S, et al. CRISPR repair reveals causative mutation in a preclinical model of retinitis pigmentosa. Mol Ther. 2016;24:1388–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kofoed RH, Dibia CL, Noseworthy K, Xhima K, Vacaresse N, Hynynen K, et al. Efficacy of gene delivery to the brain using AAV and ultrasound depends on serotypes and brain areas. J Control Release. 2022;351:667–80.

Article  CAS  PubMed  Google Scholar 

Badea A, Ali-Sharief AA, Johnson GA. Morphometric analysis of the C57BL/6J mouse brain. Neuroimage. 2007;37:683–93.

Article  CAS